Keywords: UCB, 2010 financial results

New drugs boost UCB full-year 2010 results, but 2011 looks like being tough

Article | 03 March 2011

Belgian drugmaker UCB (Euronext Brussels: UCB) announced its consolidated full year 2010 financial results yesterday, claiming it was another year of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

UCB

Go to company listing